Travoprost
تراووپروست
👁️ Sensory OrgansProstaglandin analogue (ophthalmic)
Market / country: 🇺🇸 USA
Travatan Z (US)
🧮 Dose calculator
Open-angle glaucoma / ocular hypertension · Regimen source: FDA Travatan Z · 2
- • More than once daily reduces the effect. FDA Travatan Z · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Warnings
- • Increased iris (permanent), eyelid pigmentation and eyelash changes; intraocular inflammation; macular oedema. FDA Travatan Z · 5
- • Bacterial keratitis from contaminated containers; reinsert contact lenses 15 min after. FDA Travatan Z · 5
Formulations
- 0.004% (0.04 mg/mL) eye drops — eye drops 🇺🇸 USA FDA Travatan Z · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Travatan Z · 8.1
“Risk Summary There are no adequate and well-controlled studies in pregnant women to inform a drug-associated risk.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Travatan Z · 8.2
“Risk Summary There are no data on the effects of travoprost on the breastfed child or milk production.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Travatan Z · 8.4
“Use in pediatric patients below the age of 16 years is not recommended because of potential safety concerns related to increased pigmentation following long-term chronic use.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Travatan Z · 8.5
“No overall clinical differences in safety or effectiveness have been observed between elderly and other adult patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA021994
- DailyMed (FDA label)FDA Travatan Z
- MedlinePlus (NIH)Travoprost Ophthalmic
- WHO ATC/DDDS01EE04
- Darooyab (Iran)Travoprost
🇮🇷 Registered in Iran Darooyab · G-3194/Travoprost
Dosage forms with Iranian generic codes, per Darooyab.
- 09536 · TRAVOPROST 0.04MG 2.5ML OPHTH DROP · قطره تراووپروست ۰٫۰۴ میلیگرم ۲٫۵ میلیلیتر افت
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Travatan Z · 3FDA Travatan Z · 2FDA Travatan Z · 5FDA Travatan Z · SPL approval / marketing categoryFDA Travatan Z · 8.1FDA Travatan Z · 8.2FDA Travatan Z · 8.4FDA Travatan Z · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3194/Travoprost
- Clinical review⚠ Unverified